Second Generation Product definition

Second Generation Product means, with respect to a particular Licensed Product that has achieved Regulatory Approval in a Major Market (the "Original Licensed Product"), any Licensed Product that contains a different active ingredient from that in the Original Licensed Product and that is directed against the same Mammalian Target as the Original Licensed Product, which is developed by or on behalf of BMS or its Affiliate or sublicensee as an improvement upon or potential successor to the Original Licensed Product. For clarity, it is understood that "Second Generation Product" shall not include new formulations, presentations, salts, or modes of delivery of the active ingredient contained in the Original Licensed Product.
Second Generation Product means any Combination Product containing or comprising the compound known as ABT-493, a Product that is an HCV NS3/4A protease inhibitor, and one or more other ingredients that are therapeutically or biologically active and are not themselves Products. For purposes of clarity, a Second Generation Product may consist of more than one combination, each containing ABT-493.
Second Generation Product means any oral typhoid vaccine which is derived from recombinant attenuated strains of Salmonella typhi possessing; []* * This portion of the Exhibit has been omitted pursuant to a Request for Confidential Treatment under Rule 406 of the Securities Act of 1933, as amended. The complete Exhibit, including the portions for which confidential treatment has been requested, has been filed separately with the Securities and Exchange Commission.

Examples of Second Generation Product in a sentence

  • Notwithstanding the foregoing, the API to be supplied by Noramco free of charge shall include (i) up to [***] of API for the development of the First-Generation Product, (ii) up to [***] of API in connection with the development of the Second-Generation Product, (iii) up to [***] of API in connection with the commercial launch of the First-Generation Product, and (iv) at least [***] of API, in connection with the commercial launch of the Second- Generation Product.

  • Noramco shall, free of charge, assist the Buyer in identifying third party service providers that can assist in the development of a Second- Generation Product.

  • Our results suggest that investors react negatively to SEOs during good economic times (alpha decreases and beta increases in the year after issuance) and more positively to SEOs during recessions.

  • With respect to Second Generation Products, milestone payments for second and third indications may be triggered by any Second Generation Product (i.e., not necessarily the Second Generation Product that triggered the initial payment for any indication, or the payment for a second indication).

  • The Plaintiff respectfully prays that upon a final hearing of this case, judgment be entered for him against the Defendants, for damages in an amount within the jurisdictional limits of the Court; together with pre-judgment interest at the maximum rate allowed by law; post- judgment interest at the legal rate; back pay; costs of court; attorney fees; and such other and further relief to which the Plaintiff may be entitled at law or in equity.


More Definitions of Second Generation Product

Second Generation Product means a formulation comprising Hydrogel Polymer in combination with a Ciba/Chiron Compound selected pursuant to Article 3 (whether or not also including a Radiopharmaceutical), together with all applicable Delivery Systems, in each case for use within the Field. Notwithstanding the foregoing, except as provided under Section 2.2 below, Second Generation Products shall not include any such formulation incorporating [*] or Ciba/Chiron Compound that is a Platelet Antagonist.
Second Generation Product means any erythropoietin product or service that is: (a) any derivative, modification, mutant, fragment or peptide analog of erythropoietin or (b) any other therapy involving the administration of erythropoietin such as gene or cell therapy processes or cell therapy products, carrier systems, fusion proteins, polymers and peptides. For purposes of clarity, the definition of Second Generation Product does not include any small molecule. For the purpose of clarity, the definition of Second Generation Product includes versions of GA-EPO that are long acting.
Second Generation Product means: (a) a follow-on Genentech Product that (i) in the case of a Genentech Product that is a Soluble Receptor Protein, incorporates the same therapeutically relevant sequences as are incorporated in an existing Genentech Product, or (ii) in the case of a Genentech Product that is a Target Modulator, is directed at or otherwise interacts with the same target that an existing Genentech Target Modulator Product is directed at or otherwise interacts with; provided that in each case (i) and (ii) above, such follow-on Genentech Product is developed for the same indication(s) as that existing Genentech Product; or (b) a follow-on Renovis Target Modulator Product that is directed at or otherwise interacts with the same target that an existing Renovis Target Modulator Product is directed at or otherwise interacts with, provided such follow-on Renovis Target Modulator Product is developed for the same indication(s) as that existing Renovis Target Modulator Product.
Second Generation Product means a Product containing a different Selected Scaffold from any Selected Scaffold in a Commercialized Product but which contains, as its active ingredient, a Program Antibody that is generated using the same Merck Sequence Pair as the Program Antibody that is the active ingredient in the Commercialized Product and which requires at least one new Phase III Clinical Trial to receive a Marketing Authorization.
Second Generation Product means any product comprising a Second Generation Agent.
Second Generation Product has the meaning set forth in Section 6.5.2(b).
Second Generation Product means any injectible formulation or other formulation for local administration, or any formulation for controlled or sustained release, of a Taxoid(s) (an “Formulated Taxoid”), other than the Existing Product, which is being developed or commercialized by or under the authority of MacroMed, or in which MacroMed otherwise has an interest, at any time during the term of this Agreement. It is understood that each Second Generation Product shall include any modifications made thereto in order to obtain Marketing Approval in either Party’s Territory. Notwithstanding the foregoing, Second Generation Product shall not include the HySolv® or ReSolv® formulation of a Taxoid, which are IV and oral formulations respectively.